Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Red Biotechnology Market Outlook

The global red biotechnology market attained USD 386.57 billion in 2023 and is expected to grow at a CAGR of 6.20% during the forecast period of 2024-2032 to reach a value of USD 662.98 billion by 2032.

Global Red Biotechnology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

It is anticipated that the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules will drive the global red biotechnology market.

Market Segmentation

Red biotechnology is a bio-pharmaceutical that involves the utilization of organisms to enhance health care and aid the body in fighting diseases.

Global Red Biotechnology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The global red biotechnology market is segmented into applications and end-uses.

Based on applications, the red biotechnology market can be segmented as:

  • Biopharmaceutical Production
  • Gene Therapy
  • Pharmacogenomics
  • Genetic Testing

Based on end-uses, the red biotechnology market can be divided as:

  • Pharmaceutical Industry
  • CMO and CRO 
  • Research Institutes
  • Others

The EMR report looks into the regional red biotechnology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Market Analysis

Owing to the increasing demand for gene therapy, clinical research, and trials, the industry for red biotechnology is increasing. People have begun to preserve their stem cells at the moment of birth because of growing awareness, and red biotechnology makes an enormous profit in this segment. The red biotechnology market is aided by the growth of pharmaceutical companies. With the increasing number of patients suffering from cancer globally, red biotechnology applications are becoming common as it helps to understand the cause of the disease, thus, further aiding the growth of the red biotechnology market. The industry is being fuelled by the increased financing in the healthcare industry.

Global Red Biotechnology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global red biotechnology industry, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc. (NYSE: PFE)
  • Biogen Inc. 
  • Amgen Inc. 
  • AstraZeneca Plc. 
  • Gilead Sciences, Inc. 
  • F. Hoffmann-La Roche, Ltd. 
  • Merck KGaA 
  • Bristol-Myers Squibb Company
  • Regeneron Pharmaceuticals Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Application
  • End Use
  • Region
Breakup by Application
  • Biopharmaceutical Production
  • Gene Therapy
  • Pharmacogenomics
  • Genetic Testing
Breakup by End Use
  • Pharmaceutical Industry
  • CMO & CRO
  • Research Institutes
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Biogen Inc.
  • Amgen Inc.
  • Astrazeneca Plc.
  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche, Ltd.
  • Merck KGaA  
  • Bristol-Myers Squibb Company
  • Regeneron Pharmaceuticals Inc.
  • Others 
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global red biotechnology market attained a value of nearly USD 386.57 billion.

The market is projected to grow at a CAGR of 6.20% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 662.98 billion by 2032.

The major drivers of the market, such as the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules, are expected to aid the market growth.

The key market trend guiding the market growth include the rising investments into the healthcare market.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Biopharmaceutical production, gene therapy, pharmacogenomics, and genetic testing are the leading application segments of the product in the market.

Pharmaceutical market, CMO and CRO, and research institutes, among others, are the significant end-uses of the product in the market.

The major players in the market are Pfizer Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., F. Hoffmann-La Roche, Ltd., Merck KGaA, Bristol-Myers Squibb Company, and Regeneron Pharmaceuticals Inc., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124